The LifeSignals UbiqVue 2A is now officially certified under the EU MDR (European Union Medical Device Regulation), which allows it to be marked with the CE symbol. This means it can be utilized in medical environments throughout the EU.
Connectivity Features
This wearable device incorporates 802.11b Wi-Fi, Bluetooth 5.2 LE, and MBAN wireless technologies. Such features enable the unit to transmit 12 different health parameters, in addition to data on falls, movement, and posture, directly to healthcare professionals remotely. All data transfers comply with HIPAA and GDPR regulations to ensure privacy. If there is no data communication, the internal memory can keep information for as long as 12 hours. The device is powered by a lithium manganese dioxide (LiMnO2) battery, which lasts up to five days for a single use.
Advantages for Healthcare Providers
With the UbiqVue 2A, the need for multiple devices is significantly lessened, making it easier for healthcare workers and patients alike. Key health metrics monitored include blood oxygen saturation, heart rate, respiratory rate, and body temperature. Additionally, the device features a two-channel electrocardiogram, offering deeper insights into the well-being of heart patients during their recovery. Individuals with heart issues can also keep track of their condition using a smartphone alongside the KardiaMobile Personal EKG Monitor, which is available for purchase on Amazon.
Monitoring Capabilities
The biosensor is equipped with a gyroscope and accelerometer that continually track patient movements and their positions, allowing healthcare providers to be alerted to potential issues such as falls. The device measures 4.6 x 3.6 x 0.7 inches (116 x 91 x 17 mm), weighs 1.23 ounces (35 g), and has an IP24 rating for resistance against water splashes.
LifeSignals, press release from LifeSignals, LifeSignals Group on YouTube
December 4, 2024
This cloud-based system, including a wearable biosensor designed for chest-based SpO2 monitoring, supports ongoing patient observation in both hospital and at-home care environments.
Source: Link
